Farname Inc. in collaboration with Iranian Society of Gynecology Oncology

Authors

1 Department of Gynecology Oncology, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Thoracic Surgery, Tehran University of Medical Sciences, Tehran, Iran

3 Department of pathology, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Introduction: Synovial sarcoma of the ovary is a very rare tumor reported only once in the past. It is the second softest tissue mass after rhabdomyosarcoma in adults but its usual site is extremities not ovary.
Case Presentation: Here we describe a 53-year-old woman with primary synovial sarcoma of the ovary with insufficient treatment and lung metastasis of the tumor.
Conclusions: Because of harmlessness symptoms, it is usually missed and correct treatment is delayed. When facing this type of tumor, referring to well-equipped centers with experienced surgeons in this field is recommended for sufficient treatment and best results.

Keywords

  1. Smith CJ, Ferrier AJ, Russell P, Danieletto S. Primary synovial sarcoma of the ovary: first reported case. Pathology. 2005;37(5):385-7. [DOI:10.1080/00313020500254339] [PMID]
  2. Mallen-St Clair J, Arshi A, Abemayor E, St John M. Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database. JAMA Otolaryngol Head Neck Surg. 2016;142(6):576-83. [DOI:10.1001/jamaoto.2016.0384] [PMID]
  3. Deshmukh R, Mankin HJ, Singer S. Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res. 2004(419):155-61. [DOI:10.1097/00003086-200402000-00025]
  4. Yanan W, Wenzhi B, Gang H, Jinpeng J. Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma. World J Surg Oncol. 2017;15(101). [DOI:10.1186/s12957-017-1165-9] [PMID]
  5. Fletcher CDM, Unni KK, Mertens F. World health organization classification of tumours: Pathology and genetics of tumours of soft tissue and bone. Lyon,France: IARC Press; 2002.
  6. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62(1):135-40.
  7. Krieg AH, Hefti F, Speth BM, Jundt G, Guillou L, Exner UG, et al. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol. 2011;22(2):458-67. [DOI:10.1093/annonc/mdq394] [PMID]
  8. Makhlouf HR, Ahrens W, Agarwal B, Dow N, Marshalleck JJ, Lee EL, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol. 2008;32(2):275-81. [DOI:10.1097/PAS.0b013e31812e6a58] [PMID]
  9. Drozenova J, Povysil C, Tvrdik D, Babjuk M, Hanus T. [Primary synovial sarcoma of the kidney]. Cesk Patol. 2008;44(1):20-2.
  10. Dundr P, Fischerova D, Povysil C, Tvrdik D, Cibula D. Primary synovial sarcoma of the uterus. Pathol Oncol Res. 2012;18(2):529-33. [DOI:10.1007/s12253-011-9391-x] [PMID]
  11. Campbell C, Gallagher J, Dickinson I. Synovial sarcoma-towards a simplified approach to prognosis. ANZ J Surg. 2004;74(9):727-31. [DOI:10.1111/j.1445-1433.2004.03144.x] [PMID]
  12. Bernardo V, Harris G. Synovial cell sarcoma treatment and management. Medscape. 2016;22.
  13. Shields TW, LoCicero J, Reed CE, Feins RH, editors. General Thoracic Surgery. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009. p. 1619.